Brief: Nuvation Bio To Collaborate With Thermo Fisher Scientific For U.S.-Based Manufacturing Of Ibtrozi For Ros1-Positive Non-Small Cell Lung Cancer
13/05/2026 22:54
May 13 (Reuters) - Nuvation Bio Inc NUVB.N: NUVATION BIO TO COLLABORATE WITH THERMO FISHER SCIENTIFIC FOR U.S.-BASED MANUFACTURING OF IBTROZI® FOR ROS1-POSITIVE NON-SMALL CELL LUNG CANCER Source text: ID:nPnbMn1YWa Further company coverage: NUVB.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth